Stay updated on NSCLC Progressed Anti-PD-1 Clinical Trial
Sign up to get notified when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.

Latest updates to the NSCLC Progressed Anti-PD-1 Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision labels updated to v3.4.2 with v3.4.1 removed, and there are no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedDifference0.1%

- Check32 days agoChange DetectedThe page now displays a glossary and new results metadata (Results First Posted, Last Update Submitted that Met QC Criteria, Last Update Posted), while removing a few estimated data fields and the previous revision label.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a consolidated Locations section listing California, District of Columbia, Illinois, Maryland, Massachusetts, Missouri, New York, Pennsylvania, Tennessee, Texas, Virginia, Alberta, Ontario, and Quebec; removed the previous per-state and per-province location subsections.SummaryDifference0.9%

- Check89 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2. This is a minor administrative update with no changes to study content or participant information.SummaryDifference0.0%

Stay in the know with updates to NSCLC Progressed Anti-PD-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.